Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator

Inflammation

Volumn 37, Issue 3, 2014, Pages 801-808

  Bradham, William S ^a   Ormseth, Michelle J ^a   Oeser, Annette ^a   Solus, Joseph F ^b   Gebretsadik, Tebeb ^a   Shintani, Ayumi ^a   Stein, C Michael ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IL 6; inflammation; insulin resistance; natriuretic peptides; obesity; rheumatoid arthritis; TNF alpha

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; IL6 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RHEUMATOID ARTHRITIS; SEX RATIO; SYSTOLIC BLOOD PRESSURE; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902550868     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9799-4     Document Type: Article

References (40)

1. McCullough, P.A., R.M. Nowak, J. McCord, J.E. Hollander, H.C. Herrmann, P.G. Steg, P. Duc, A. Westheim, T. Omland, C.W. Knudsen, A.B. Storrow, W.T. Abraham, S. Lamba, A.H. Wu, A. Perez, P. Clopton, P. Krishnaswamy, R. Kazanegra, and A.S. Maisel. 2002. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 106: 416-422. (Pubitemid 34803684)
2. Maisel, A.S., P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough. 2002. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England Journal of Medicine 347: 161-167. (Pubitemid 34764819)
3. McKie, P.M., R.J. Rodeheffer, A. Cataliotti, F.L. Martin, L.H. Urban, D.W. Mahoney, S.J. Jacobsen, M.M. Redfield, and J.C. Burnett Jr. 2006. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension 47: 874-880. (Pubitemid 44297558)
4. Wang, T.J., M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, and R.S. Vasan. 2004. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. The New England Journal of Medicine 350: 655-663. (Pubitemid 38364624)
5. Kistorp, C., I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt. 2005. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616. (Pubitemid 40471791)
6. Kenchaiah, S., J.C. Evans, D. Levy, P.W. Wilson, E.J. Benjamin, M.G. Larson, W.B. Kannel, and R.S. Vasan. 2002. Obesity and the risk of heart failure. The New England Journal of Medicine 347(5): 305-313. (Pubitemid 34815352)
7. Levitan, E.B., A.Z. Yang, A. Wolk, and M.A. Mittleman. 2009. Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circulation Heart Failure 2(3): 202-208.
8. Wang, T.J., M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, P.W. Wilson, and R.S. Vasan. 2004. Impact of obesity on plasma natriuretic peptide levels. Circulation 109(5): 594-600. (Pubitemid 38198866)
9. Wang, T.J., M.G. Larson, M.J. Keyes, D. Levy, E.J. Benjamin, and R.S. Vasan. 2007. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115(11): 1345-1353. (Pubitemid 46648370)
10. Hanley, A.J., K. Williams, M.P. Stern, and S.M. Haffner. 2002. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25: 1177-1184. (Pubitemid 41071169)
11. Geloneze, B., E.M. Repetto, S.R. Geloneze, M.A. Tambascia, and M.N. Ermetice. 2006. The threshold value for insulin resistance (HOMA-IR) in an admixture population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Research and Clinical Practice 72: 219-220.
12. Bonora, E., S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J.B. Meigs, R.C. Bonadonna, and M. Muggeo. 2007. Insulin resistance as estimated by Homeostasis Model Assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population. The Bruneck Study Diabetes Care 30: 318-324. (Pubitemid 46198337)
13. Khan, A.M., S. Cheng, M. Magnusson, M.G. Larson, C. Newton-Cheh, E.L. McCabe, A.D. Coviello, J.C. Florez, C.S. Fox, D. Levy, S.J. Robins, P. Arora, S. Bhasin, C.S. Lam, R.S. Vasan, O. Melander, and T.J. Wang. 2011. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. The Journal of Clinical Endocrinology and Metabolism 96(10): 3242-3249.
14. Meisinger, C., A. Döring, B. Thorand, M. Heier, and H. Löwel. 2006. Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. American Journal of Clinical Nutrition 84(3): 483-489. (Pubitemid 44713396)
15. Li, C.L., S.T. Tsai, and P. Chou. 2003. Relative role of insulin resistance and beta-cell dysfunction in the progression to type 2 diabetes - the Kinmen Study. Diabetes/Metabolism Research and Reviews 59: 225-232. (Pubitemid 36183307)
16. Meune, C., E. Touze, L. Trinquart, and Y. Allanore. 2009. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 48(10): 1309-1313.
17. Avina-Zubieta, J.A., H.K. Choi, M. Sadatsafavi, M. Etminan, J.M. Esdaile, and D. Lacaille. 2008. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis and Rheumatism 59(12): 1690-1697.
18. Nicola, P.J., H. Maradit-Kremers, V.L. Roger, S.J. Jacobsen, C.S. Crowson, K.V. Ballman, and S.E. Gabriel. 2005. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis and Rheumatism 52(2): 412-420. (Pubitemid 40216304)
19. Solus, J., C.P. Chung, A. Oeser, I. Avalos, T. Gebretsadik, A. Shintani, P. Raggi, T. Sokka, T. Pincus, and C.M. Stein. 2008. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis and Rheumatism 58(9): 2662-2669.
20. Armstrong, D.J., P.V. Gardiner, and M.J. O'Kane. 2010. Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher Brain Natriuretic Peptide (BNP) levels than patients with inactive disease or healthy control subjects. The Ulster Medical Journal 79(2): 82-84.
21. Chung, C.P., A. Oeser, J.F. Solus, T. Gebretsadik, A. Shintani, I. Avalos, T. Sokka, P. Raggi, T. Pincus, and C.M. Stein. 2008. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis and Rheumatism 58(7): 2105-2112. (Pubitemid 351988102)
22. Liao, K.P., and D.H. Solomon. 2012. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford) 2013 52(1): 45-52.
23. Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, and H.S. Luthra. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31(3): 315-324. (Pubitemid 18091653)
24. Prevoo, M.L., M.A. van't Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel. 1995. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38: 44-48.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA May 16;285(19):2486-97.
26. Reilly, M.P., M.L. Wolfe, T. Rhodes, C. Girman, N. Mehta, and D.J. Rader. 2004. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110: 803-809. (Pubitemid 39096007)
27. Kosuke, I., L. Keele, and T. Yamamoto. 2010. Identification, inference, and sensitivity analysis for causal mediation effects. Statistical Science 1: 51-71.
28. Tingley D, Yamamoto T, Keele L, Kosuke I 2013 mediation: R package for causal mediation analysis. R package version 4.2.3. URL http://CRAN.R-project. org/package=mediation.
29. Semonov, A.G., and K.R. Seferian. 2011. Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing. Clinica Chimica Acta 412: 850-860.
30. McKie, P.M., A. Cataliotti, B.D. Lahr, F.L. Martin, M.M. Redfield, K.R. Bailey, R.J. Rodeheffer, and J.C. Burnett. 2010. The prognostic value of N-terminal Pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. JACC 55(19): 2140-2147.
31. Motiwala, S.R., and J.L. Januzzi. 2013. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Clinical Pharmacology and Therapeutics 93(1): 57-67.
32. Panagopoulou, V., S. Deftereos, C. Kossyvakis, K. Raisakis, G. Giannopoulos, G. Bouras, V. Pyrgakis, and M.W. Cleman. 2013. NTproBNP: an important biomarker in cardiac diseases. Current Topics in Medicinal Chemistry 13(2): 82-94.
33. Cheng, S., C.S. Fox, M.G. Larson, J.M. Massaro, E.L. McCabe, A.M. Khan, D. Levy, U. Hoffmann, C.J. O'Donnell, K.K. Miller, C. Newton-Cheh, A.D. Coviello, S. Bhasin, R.S. Vasan, and T.J. Wang. 2011. Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. The American Journal of Cardiology 108(7): 979-984.
34. Fradley, M.G., M.G. Larson, S. Cheng, E. McCabe, E. Coglianese, R.V. Shah, D. Levy, R.S. Vasan, and T.J. Wang. 2011. Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). The American Journal of Cardiology 108(9): 1341-1345.
35. Fox, E.R., S.K. Musani, A. Bidulescu, H.S. Nagarajarao, T.E. Samdarshi, S.Y. Gebreab, J.H. Sung, M.W. Steffes, T.J. Wang, H.A. Taylor, and R.S. Vasan. 2011. Relation of obesity to circulating B-type natriuretic peptide concentrations in blacks: the Jackson Heart Study. Circulation 124(9): 1021-1027.
36. Halbirk, M., H. Norrelund, N. Moller, O. Schmitz, H.E. Botker, and H. Wiggers. 2009. Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. International Journal of Cardiology 144: 140-142.
37. Tanabe, A., M. Naruse, T. Wasada, K. Naruse, T. Yoshimoto, Y. Omori, and H. Demura. 1995. Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. European Journal of Endocrinology 132: 693-698.
38. Jarai, R., C. Kaun, T.W. Weiss, W.S. Speidl, K. Rychli, G. Maurer, K. Huber, and J. Wojta. 2009. Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta. Journal of Cellular and Molecular Medicine 13(11-12): 4415-4421.
39. Choi, J., L. Joseph, and L. Pilote. 2013. Obesity and C-reactive protein in various populations: a systematic review andmeta-analysis. Obesity Reviews 14(3): 232-244.
40. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444(7121): 860-867. (Pubitemid 46024993)